Pharmacy Department, Adelaide and Meath Hospital, incorporating the National Children's Hospital (AMNCH), Tallaght, Dublin 24 School of Pharmacy , Trinity College, Dublin 2, Ireland.
Br J Clin Pharmacol. 2011 Mar;71(3):449-57. doi: 10.1111/j.1365-2125.2010.03834.x.
Movement into or out of hospital is a vulnerable period for medication safety. Reconciling the medication a patient is using before admission with the medication prescribed on discharge, and documenting any changes (medication reconciliation) is recommended to improve safety. The aims of the study were to investigate the factors contributing to medication reconciliation on discharge, and identify the prevalence of non-reconciliation.
The study was a cross-sectional, observational survey using consecutive discharges from purposively selected services in two acute public hospitals in Ireland. Medication reconciliation, potential for harm and unplanned re-admission were investigated.
Medication non-reconciliation was identified in 50% of 1245 inpatient episodes, involving 16% of 9569 medications. The majority of non-reconciled episodes had potential to result in moderate (63%) or severe (2%) harm. Handwritten rather than computerized discharges (adjusted odds ratio (adjusted OR) 1.60, 95% CI 1.11, 2.99), increasing number of medications (adjusted OR 1.26, 95% CI 1.21, 1.31) or chronic illness (adjusted OR 2.08, 95% CI 1.33, 3.24) were associated with non-reconciliation. Omission of endocrine, central nervous system and nutrition and blood drugs was more likely on discharge, whilst omission on admission and throughout inpatient care, without documentation, was more likely for obstetric, gynaecology and urinary tract (OGU) or respiratory drugs. Documentation in the discharge communication that medication was intentionally stopped during inpatient care was less likely for cardiovascular, musculoskeletal and OGU drugs. Errors involving the dose were most likely for respiratory drugs.
The findings inform strategies to facilitate medication reconciliation on discharge from acute hospital care.
患者入院或出院期间是药物安全的脆弱时期。建议在出院时核对患者入院前使用的药物与出院时开的药物,并记录任何变化(药物重整),以提高安全性。本研究旨在调查导致出院时药物重整的因素,并确定未进行药物重整的发生率。
本研究是一项在爱尔兰两家急性公立医院有针对性选择的服务中连续出院的横断面观察性调查。研究调查了药物重整、潜在危害和非计划性再入院的情况。
在 1245 例住院病例中,有 50%存在药物未重整,涉及 9569 种药物中的 16%。大多数未重整的病例都有可能导致中度(63%)或严重(2%)的危害。手写而非计算机化的出院记录(校正优势比(adjusted OR) 1.60,95%置信区间(95% CI) 1.11,2.99)、药物数量增加(adjusted OR 1.26,95% CI 1.21,1.31)或慢性疾病(adjusted OR 2.08,95% CI 1.33,3.24)与未重整相关。出院时更有可能遗漏内分泌、中枢神经系统和营养与血液药物,而在入院时和整个住院期间遗漏但无记录的情况,更有可能发生妇产科和泌尿系统(OGU)或呼吸系统药物。在出院沟通中记录药物在住院期间被故意停止的情况,更不可能发生心血管、肌肉骨骼和 OGU 药物。涉及剂量的错误最有可能发生在呼吸系统药物中。
这些发现为从急性医院护理出院时促进药物重整的策略提供了信息。